A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

Conditions: Systemic Lupus Erythematosus Interventions: Biological: RJMty19 (CD19-CAR-DNT cells) Sponsors: Guangdong Ruishun Biotech Co., Ltd; RenJi Hospital; Peking University People ' s Hospital; Changhai Hospital; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials